Implantica Future Growth
Future criteria checks 5/6
Implantica is forecast to grow earnings and revenue by 42.9% and 92.2% per annum respectively while EPS is expected to grow by 34.4% per annum.
Key information
42.9%
Earnings growth rate
34.4%
EPS growth rate
| Medical Equipment earnings growth | 14.2% |
| Revenue growth rate | 92.2% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 18 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 25 | -22 | N/A | N/A | 1 |
| 12/31/2025 | 6 | -29 | N/A | N/A | 1 |
| 12/31/2024 | 2 | -22 | N/A | N/A | 1 |
| 9/30/2024 | 2 | -25 | -26 | -25 | N/A |
| 6/30/2024 | 2 | -24 | -27 | -25 | N/A |
| 3/31/2024 | 2 | -23 | -25 | -22 | N/A |
| 12/31/2023 | 1 | -24 | -24 | -20 | N/A |
| 9/30/2023 | 1 | -20 | -22 | -17 | N/A |
| 6/30/2023 | 1 | -20 | -23 | -16 | N/A |
| 3/31/2023 | 1 | -21 | -24 | -16 | N/A |
| 12/31/2022 | 1 | -21 | -25 | -16 | N/A |
| 9/30/2022 | 1 | -22 | -25 | -15 | N/A |
| 6/30/2022 | 1 | -21 | -24 | -16 | N/A |
| 3/31/2022 | 1 | -18 | -21 | -14 | N/A |
| 12/31/2021 | 0 | -15 | -17 | -11 | N/A |
| 9/30/2021 | 0 | -12 | -20 | -16 | N/A |
| 6/30/2021 | 0 | -13 | -14 | -11 | N/A |
| 3/31/2021 | 0 | -11 | -13 | -10 | N/A |
| 12/31/2020 | 0 | -10 | -12 | -10 | N/A |
| 9/30/2020 | 0 | -8 | -4 | -2 | N/A |
| 12/31/2019 | 0 | -5 | -6 | -4 | N/A |
| 12/31/2018 | 0 | -5 | -8 | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 8IM1 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).
Earnings vs Market: 8IM1 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 8IM1 is expected to become profitable in the next 3 years.
Revenue vs Market: 8IM1's revenue (92.2% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 8IM1's revenue (92.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 8IM1's Return on Equity is forecast to be high in 3 years time